These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET. Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127 [TBL] [Abstract][Full Text] [Related]
5. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135 [TBL] [Abstract][Full Text] [Related]
6. LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer. Lindquist D; Alsina FC; Herdenberg C; Larsson C; Höppener J; Wang N; Paratcha G; Tarján M; Tot T; Henriksson R; Hedman H Int J Oncol; 2018 Apr; 52(4):1189-1197. PubMed ID: 29436694 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of RET receptor isoforms in the olfactory system. Kaplinovsky T; Cunningham AM Neuroscience; 2011 Feb; 175():49-65. PubMed ID: 21118713 [TBL] [Abstract][Full Text] [Related]
8. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
9. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Le Hir H; Charlet-Berguerand N; Gimenez-Roqueplo A; Mannelli M; Plouin P; de Franciscis V; Thermes C Oncology; 2000 May; 58(4):311-8. PubMed ID: 10838497 [TBL] [Abstract][Full Text] [Related]
11. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C? Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926 [TBL] [Abstract][Full Text] [Related]
12. A Homozygous RET K666N Genotype With an MEN2A Phenotype. Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964 [TBL] [Abstract][Full Text] [Related]
13. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation]. Zhu XL; Zhou XY; Zhang TM; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Romei C; Ciampi R; Elisei R Nat Rev Endocrinol; 2016 Apr; 12(4):192-202. PubMed ID: 26868437 [TBL] [Abstract][Full Text] [Related]
16. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer. Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667 [TBL] [Abstract][Full Text] [Related]
17. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Biscolla RP; Ugolini C; Sculli M; Bottici V; Castagna MG; Romei C; Cosci B; Molinaro E; Faviana P; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R Thyroid; 2004 Nov; 14(11):946-52. PubMed ID: 15671773 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors. Barollo S; Bertazza L; Watutantrige-Fernando S; Censi S; Cavedon E; Galuppini F; Pennelli G; Fassina A; Citton M; Rubin B; Pezzani R; Benna C; Opocher G; Iacobone M; Mian C PLoS One; 2016; 11(5):e0156044. PubMed ID: 27224648 [TBL] [Abstract][Full Text] [Related]
19. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study. Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957 [TBL] [Abstract][Full Text] [Related]
20. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]